Orexin Receptor Antagonist Treatment for Insomnia

Clinical Indications

• Suvorexant is specifically indicated for sleep maintenance insomnia (difficulty staying asleep) 1, 2, 3
• It has demonstrated efficacy in reducing wake time after sleep onset by 16-28 minutes compared to placebo 3

Treatment Approach

• The American Academy of Sleep Medicine indicates that suvorexant improves subjective total sleep time, with clinical trials showing improvements of 22.3-49.9 minutes at doses of 10-20 mg, although the exact details of these trials are not specified here 3
• Reevaluate if insomnia persists after 7-10 days of treatment to rule out comorbid conditions, as suggested by Praxis Medical Insights 4